2023-08-31  9:59:59 PM Chg. - Volume Bid1:50:00 AM Ask1:50:00 AM Market Capitalization Dividend Y. P/E Ratio
39.7500USD - 31.37 mill.
Turnover: 336.35 mill.
39.2900Bid Size: - 39.9000Ask Size: - 2.08 bill.USD - 50.96

Business description

NuVasive is a global medical device company focused on transforming spine surgery by empowering surgeons with technology to approach procedures in the least disruptive way possible and restore the vitality of life for those that suffer from debilitating spinal conditions. Through its minimally invasive, procedurally-integrated solutions, the Company is expanding the boundaries of modern healthcare with technologies and surgeon training designed to provide reproducible and clinically-proven surgical outcomes that are redefining the success factors of spine surgery like never before. Addressing a variety of pathologies up and down the spine, from complex spinal deformity to degenerative spinal conditions, NuVasive's highly differentiated solutions include access instruments, implantable hardware and increasingly expert software systems like its game-changing iGA™ surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. NuVasive believes its integrated approach and expertise can fundamentally evolve spine care by delivering improved patient experiences, and better economics for healthcare systems.
 

Management board & Supervisory board

CEO
J. Christopher Barry
Management board
Matthew K. Harbaugh, Aviva McPherron, Brent Boucher, Dale Wolf, Kyle Malone, Lucas Vitale, Massimo Calafiore, Michael Farrington, Nathaniel Sisitsky, Sean Freeman
Supervisory board
Daniel J. Wolterman, Amy Belt Raimundo, Donald J. Rosenberg, J. Christopher Barry, John A. DeFord, Leslie V. Norwalk, R. Scott Huennekens, Robert F. Friel, Siddhartha Kadia, Vickie L. Capps
 

Company data

Name: NuVasive Inc.
Address: 7475 Lusk Boulevard,San Diego, California 92121, USA
Phone: +1-858-909-1800
Fax: +1-800-475-9134
E-mail: info@nuvasive.com
Internet: www.nuvasive.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12-31
Free Float: 60.20%
IPO date: -

Investor relations

Name: Juliet C. Cunningham
IR phone: +1-858-458-2240
IR Fax: -
IR e-mail: investorrelations@nuvasive.com

Main Shareholders

Freefloat
 
60.20%
Wellington Management Company LLP
 
13.00%
BlackRock, Inc.
 
12.20%
The Vanguard Group
 
9.40%
The Hartford Mutual Funds, Inc.
 
5.20%